YZ
Yun Zhong Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
31%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.6%
Neutral
17.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $273 |
14%
upside
| 4 | +9.4% |
0
%
| 12 Feb ‘26 20 days ago |
|
|
|
Outperform
Maintained
| $34 |
114%
upside
| 2 | -14% |
0
%
| 23 Jan ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $2 |
35%
downside
| 1 | +64% |
–
| 8 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $33 |
146%
upside
| 3 | +42% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $16 |
19%
upside
| 3 | – |
–
| 6 Nov ‘25 3 months ago |
|
|
|
Outperform
Initiated
| $8 |
88%
upside
| 1 | +120% |
0
%
| 29 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $86 |
6%
downside
| 2 | +37% |
0
%
| 28 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $18 |
2%
upside
| 1 | +183% |
0
%
| 30 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $40 |
400%
upside
| 1 | +43% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $28 |
398%
upside
| 1 | -36% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $8 |
97%
upside
| 2 | +2.7% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $8 |
103%
upside
| 1 | +97% |
0
%
| 27 May ‘25 9 months ago |
|
|
|
Outperform
Reiterated
| $32 |
567%
upside
| 1 | -29% |
0
%
| 16 May ‘25 9 months ago |
|